The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
Fuente:
Wiley Open Access
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2024
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1867005521352982528 |
|---|---|
| author | Iskandar Idris |
| author_facet | Iskandar Idris Iskandar Idris |
| collection | Wiley Open Access |
| contents | The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH) Iskandar Idris Diabetes, Obesity and Metabolism Now 10.1002/doi2.92 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1002/doi2.92 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_doi2_92 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH) Iskandar Idris Diabetes, Obesity and Metabolism Now The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH) Iskandar Idris Diabetes, Obesity and Metabolism Now 10.1002/doi2.92 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH) |
| topic | Diabetes, Obesity and Metabolism Now |
| url | https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1002/doi2.92 |